💡 The CTech™ SoloVPER System improves accuracy by correcting for light scattering from lipid nanoparticles.
🔬 This method effectively quantifies mRNA after encapsulation, ensuring reliable results in various applications, including vaccines and therapies.
✨ The publication highlights its successful validation, marking a significant step in molecular biology measurement techniques.
Introduction:
The article discusses advancements in the measurement of messenger RNA (mRNA) concentration using a novel approach known as Variable Pathlength Spectroscopy, specifically through the CTech™ SoloVPE System. This innovative methodology seeks to overcome challenges associated with traditional UV-Vis spectroscopy, particularly in the context of mRNA encapsulated within lipid nanoparticles (LNPs), which complicate accurate concentration assessments due to light scattering.
- The study emphasizes the critical role of mRNA in various biomedical applications, notably in vaccine development and gene therapy.
- Traditional UV-Vis spectroscopy encounters challenges in measuring mRNA concentration when it is encapsulated in lipid nanoparticles due to significant light scattering.
- The CTech™ SoloVPE System offers a solution by implementing a variable pathlength method alongside a light scattering correction algorithm.
- Validation of the SoloVPE System involved comprehensive assessment through parameters such as specificity, repeatability, linearity, and accuracy, ensuring reliability in mRNA measurements.
- Results demonstrate that the SoloVPE method successfully measured total mRNA concentration after LNP encapsulation, meeting all specified acceptance criteria for this analytical technique.
Conclusion:
The introduction of the Variable Pathlength Spectroscopy through the CTech™ SoloVPE System represents a significant improvement in accurately determining mRNA concentrations, which is crucial for the advancement of mRNA-based therapies and vaccines. This innovative method not only enhances the reliability of concentration measurements after LNP use but also potentially paves the way for future applications in other gene delivery systems, thereby broadening the scope of mRNA research and therapeutic development.
